Positivity rate of respiratory syncytial virus (RSV) using multiplex PCR test in Indonesia.

IF 1.3 4区 医学 Q4 INFECTIOUS DISEASES
Fariz Nurwidya, Ricky Tjahjadi, Arini Purwono, Linda Mahardhika, Fanny Fachrucha
{"title":"Positivity rate of respiratory syncytial virus (RSV) using multiplex PCR test in Indonesia.","authors":"Fariz Nurwidya, Ricky Tjahjadi, Arini Purwono, Linda Mahardhika, Fanny Fachrucha","doi":"10.3855/jidc.21753","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Respiratory syncytial virus (RSV) is highly prevalent as a cause of acute respiratory tract infection. Detection of RSV using nucleic acid amplification tests provides rapid results that can help physicians manage patients with acute respiratory symptoms and avoid unnecessary antibiotics. This study aimed to report the positivity rate of RSV among patients with acute respiratory symptoms.</p><p><strong>Methodology: </strong>Nasopharyngeal swab specimens were obtained from primary healthcare facilities and hospital outpatient clinics from January 2023 to June 2024. The specimens were processed using the multiplex QIAStat-Dx Respiratory SARS-CoV-2 Panel (QIAGEN GmbH, Hilden, Germany).</p><p><strong>Results: </strong>A total of 1339 tests were performed and RSV was positive in 10.3% of tested patients (138/1339). Regarding the monthly positivity rate, the highest rate of RSV positivity was in November 2023, followed by January 2023, and March 2023.</p><p><strong>Conclusions: </strong>This study shows a moderate RSV positivity rate in outpatient settings and suggests a seasonal trend, with higher circulation during the rainy season. These findings highlight the value of RSV surveillance for guiding clinical and public health responses in tropical regions.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"20 7","pages":"926-931"},"PeriodicalIF":1.3000,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3855/jidc.21753","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Respiratory syncytial virus (RSV) is highly prevalent as a cause of acute respiratory tract infection. Detection of RSV using nucleic acid amplification tests provides rapid results that can help physicians manage patients with acute respiratory symptoms and avoid unnecessary antibiotics. This study aimed to report the positivity rate of RSV among patients with acute respiratory symptoms.

Methodology: Nasopharyngeal swab specimens were obtained from primary healthcare facilities and hospital outpatient clinics from January 2023 to June 2024. The specimens were processed using the multiplex QIAStat-Dx Respiratory SARS-CoV-2 Panel (QIAGEN GmbH, Hilden, Germany).

Results: A total of 1339 tests were performed and RSV was positive in 10.3% of tested patients (138/1339). Regarding the monthly positivity rate, the highest rate of RSV positivity was in November 2023, followed by January 2023, and March 2023.

Conclusions: This study shows a moderate RSV positivity rate in outpatient settings and suggests a seasonal trend, with higher circulation during the rainy season. These findings highlight the value of RSV surveillance for guiding clinical and public health responses in tropical regions.

印度尼西亚呼吸道合胞病毒(RSV)多重PCR检测阳性率。
呼吸道合胞病毒(RSV)是引起急性呼吸道感染的一种高度流行的病毒。使用核酸扩增试验检测RSV可提供快速结果,可帮助医生管理有急性呼吸道症状的患者并避免不必要的抗生素。本研究旨在报道RSV在急性呼吸道症状患者中的阳性率。方法:从2023年1月至2024年6月从初级卫生保健机构和医院门诊获得鼻咽拭子标本。使用多重QIAStat-Dx Respiratory SARS-CoV-2面板(QIAGEN GmbH, Hilden, Germany)处理标本。结果:共进行1339次检测,10.3%的检测患者(138/1339)RSV阳性。从月阳性率来看,RSV阳性率最高的是2023年11月,其次是2023年1月和2023年3月。结论:本研究显示门诊地区RSV阳性率中等,且呈季节性趋势,雨季传播较高。这些发现突出了RSV监测在指导热带地区临床和公共卫生应对方面的价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
5.30%
发文量
239
审稿时长
4-8 weeks
期刊介绍: The Journal of Infection in Developing Countries (JIDC) is an international journal, intended for the publication of scientific articles from Developing Countries by scientists from Developing Countries. JIDC is an independent, on-line publication with an international editorial board. JIDC is open access with no cost to view or download articles and reasonable cost for publication of research artcles, making JIDC easily availiable to scientists from resource restricted regions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书